Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes by Erick De La Torre-Tarazona, Erick De La Torre-Tarazona, Rubén Ayala-Suárez, Rubén Ayala-Suárez, Rubén Ayala-Suárez, Francisco Díez-Fuertes, Francisco Díez-Fuertes, José Alcamí, José Alcamí, José Alcamí

Get full text

Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1. by Rafael Sanjuán, Miguel R Nebot, Joan B Peris, José Alcamí

Get full text

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4+ T Cells From HIV-1 Patients by Cristina Xufré, Tanía González, Tanía González, Lorna Leal, Lorna Leal, Charles M. Trubey, Jeffrey D. Lifson, José María Gatell, José Alcamí, José Alcamí, José Alcamí, Núria Climent, Núria Climent, Felipe García, Felipe García, Sonsoles Sánchez-Palomino, Sonsoles Sánchez-Palomino

Get full text

Converging roads: the latest science from the 2017 IAS HIV Cure and Cancer Forum by Genevieve E. Martin, José Alcami, Jean-Phillipe Spano, Anna Laura Ross

Get full text

Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins. by Muzafar Jan, Chitra Upadhyay, José Alcami Pertejo, Catarina E Hioe, Sunil K Arora

Get full text

Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging by Andrea Rodríguez-Agustín, Víctor Casanova, Judith Grau-Expósito, Sonsoles Sánchez-Palomino, José Alcamí, Núria Climent

Get full text

Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection by Francisco Diez-Fuertes, Francisco Diez-Fuertes, María Rosa López-Huertas, María Rosa López-Huertas, Javier García-Pérez, Javier García-Pérez, Esther Calonge, Esther Calonge, Mercedes Bermejo, Mercedes Bermejo, Elena Mateos, Elena Mateos, Pilar Martí, Pilar Martí, Nuria Muelas, Nuria Muelas, Juan Jesús Vílchez, Juan Jesús Vílchez, Mayte Coiras, Mayte Coiras, José Alcamí, José Alcamí, José Alcamí, Sara Rodríguez-Mora, Sara Rodríguez-Mora

Get full text

Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine by Roque Pastor-Ibáñez, Francisco Díez-Fuertes, Sonsoles Sánchez-Palomino, Jose Alcamí, Montserrat Plana, David Torrents, Lorna Leal, Felipe García

Get full text

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1 by María Rosa López-Huertas, Laura Jiménez-Tormo, Nadia Madrid-Elena, Carolina Gutiérrez, Sara Rodríguez-Mora, Mayte Coiras, José Alcamí, Santiago Moreno

Get full text

Elite controllers long-term non progressors present improved survival and slower disease progression by Laura Capa, Rubén Ayala-Suárez, Humberto Erick De La Torre Tarazona, Juan González-García, Jorge del Romero, José Alcamí, Francisco Díez-Fuertes

Get full text

IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle by Mayte Coiras, Mercedes Bermejo, Benjamin Descours, Elena Mateos, Javier García-Pérez, María-Rosa López-Huertas, Michael M. Lederman, Monsef Benkirane, José Alcamí

Get full text

Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection by Rubén Ayala-Suárez, Francisco Díez-Fuertes, Esther Calonge, Humberto Erick De La Torre Tarazona, María Gracia-Ruíz de Alda, Laura Capa, José Alcamí

Get full text

Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing. by Marta Montes, Mayte Coiras, Soraya Becerra, Cristina Moreno-Castro, Elena Mateos, Jara Majuelos, F Javier Oliver, Cristina Hernández-Munain, José Alcamí, Carlos Suñé

Get full text

3-Phenylcoumarins as Inhibitors of HIV-1 Replication by José Alcamí, Mahabir P. Gupta, Eduardo Muñoz, Esther del Olmo, José L. López-Pérez, Luis M. Bedoya, Rocío Sancho, Dionisio Olmedo, Arturo San Feliciano

Get full text

Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors. by Nuria González, Krisha McKee, Rebecca M Lynch, Ivelin S Georgiev, Laura Jimenez, Eulalia Grau, Eloísa Yuste, Peter D Kwong, John R Mascola, José Alcamí

Get full text

Promiscuous, Multi-Target Lupane-Type Triterpenoids Inhibits Wild Type and Drug Resistant HIV-1 Replication Through the Interference With Several Targets by Luis M. Bedoya, Luis M. Bedoya, Manuela Beltrán, Javier García-Pérez, Patricia Obregón-Calderón, Oliver Callies, Ignacio A. Jímenez, Isabel L. Bazzocchi, José Alcamí

Get full text

Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways by Dionisio A. Olmedo, José Luis López-Pérez, Esther del Olmo, Luis M. Bedoya, Rocío Sancho, José Alcamí, Eduardo Muñoz, Arturo San Feliciano, Mahabir P. Gupta

Get full text

14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to contro... by Mercedes Bermejo, Juan Ambrosioni, Guiomar Bautista, Núria Climent, Elena Mateos, Cristina Rovira, Rafael Duarte, Francisco Cervantes, Montserrat Plana, José M. Miró, José Alcamí, Mayte Coiras

Get full text

Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine. by Carmen Álvarez-Fernández, Alberto Crespo Guardo, Javier García-Pérez, Felipe García, Julia Blanco, Laura Escribà-García, Jose Maria Gatell, Jose Alcamí, Montserrat Plana, Sonsoles Sánchez-Palomino

Get full text

Exploring the HIV-1 Rev Recognition Element (RRE)–Rev Inhibitory Capacity and Antiretroviral Action of Benfluron Analogs by Sergi Chumillas, Saurabh Loharch, Manuela Beltrán, Mateusz P. Szewczyk, Silvia Bernal, Maria C. Puertas, Javier Martinez-Picado, José Alcamí, Luis M. Bedoya, Vicente Marchán, José Gallego

Get full text